A Study to Evaluate the Immunogenicity of Quadrivalent LAIV (MEDI8662) in Adults 18 to 49 Years of Age

Clinical trial NCT00952705 · COMPLETED

Trial details

NCT number: NCT00952705
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Healthy or Stable Underlying Chronic Medical Condition

Start date: 2009-08-01
Primary completion: 2010-01-01
Enrollment: 1800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.